InsiderTrades

Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2022-11-22 00:00:00 ET · period of report 2022-11-18 · accession 0001062993-22-022644 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-11-22 2022-11-18 COLL Ciaffoni Joseph Pres, CEO, Dir M - OptEx $15.90 +1,989 325.4K +0.6% +$31.6K
D 2022-11-22 2022-11-18 COLL Ciaffoni Joseph Pres, CEO, Dir S - Sale+OE $22.02 -1,989 323.5K -0.6% -$43.8K
D 2022-11-22 2022-11-18 COLL Ciaffoni Joseph Pres, CEO, Dir M - OptEx $0.00 -1,989 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-18 M A 1,989 $15.90 325,442 D — —
2 Common Common Stock 2022-11-18 S D 1,989 $22.02 323,453 D — — (F2) The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
3 Derivative Stock Option (Right to Purchase) 2022-11-18 M D 1,989 $0.00 0 D $15.90 · — to 2029-01-25 1,989 Common Stock (F3) All of the 1,989 option shares are exercisable.